Skip to main content
DYN logo

DYN · Dyne Therapeutics, Inc. · Proposed Sales

Track DYN — free
$16.40 +1.17 (+7.68%)
Market Cap
$2.84B
Shares
186.75M
Volume · Oct 20 3.39M Avg daily vol (3M) 2.98M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-09-08 Kerr Douglas 35
2026-09-08 Cox John 5,658
2026-09-04 Kerr Douglas 5,000
2026-08-13 Cox John 4,986
2026-08-13 Kerr Douglas 2,443
2026-08-13 Lucera Erick 1,797
2026-07-27 ForDyne B.V. 261,460
2026-06-25 Lucera Erick 2,362
2026-06-17 ForDyne B.V. 348,317
2026-06-16 Cox John 2,683
2026-05-13 Cox John 3,311
2026-05-13 Lucera Erick 1,448
2026-04-01 Lucera Erick 5,727
2026-03-11 ForDyne B.V. 807,295
2026-03-09 ForDyne B.V. 807,295
2026-03-05 Cox John 2,732
2025-12-05 Kerr Douglas 880
2025-12-05 Cox John 2,662
2025-09-05 Cox John 2,640
2025-09-04 Kerr Douglas 4,552
2025-06-11 Scalzo Richard William 1,330
2025-06-11 Beskrovnaya Oxana 2,132
2025-06-05 Scalzo Richard William 914
2025-06-05 Beskrovnaya Oxana 1,093
2025-06-05 Kerr Douglas 1,342
2025-06-05 Cox John 4,060
2025-05-16 Scalzo Richard William 2,479
2025-05-16 Beskrovnaya Oxana 2,589
2025-03-11 Beskrovnaya Oxana 2,153
2025-03-11 Scalzo Richard William 1,343
2025-03-05 Scalzo Richard William 915
2025-03-05 Cox John 4,067
2025-03-05 Kerr Douglas 1,343
2025-03-05 Beskrovnaya Oxana 1,094
2025-02-18 Beskrovnaya Oxana 2,598
2025-02-18 Scalzo Richard William 2,488
2024-12-11 Beskrovnaya Oxana 2,334
2024-12-11 HIGH SUSANNA GATTI 5,270
2024-12-11 Scalzo Richard William 1,455
2024-11-25 McNeill Jonathan 19,987
2024-11-22 Forbion Capital Fund IV Cooperatief U.A. 62,301
2024-11-18 Scalzo Richard William 2,735
2024-11-18 McNeill Jonathan 2,658
2024-11-18 Beskrovnaya Oxana 2,856
2024-11-18 Farwell Wildon 2,515
2024-11-18 Incerti Carlo 16,500
2024-11-18 HIGH SUSANNA GATTI 2,892
2024-11-14 ForDyne B.V. 1,500,000
2024-09-18 HIGH SUSANNA GATTI 8,967
2024-09-18 McNeill Jonathan 1,870
Showing 1–50 of 139 filings
Key facts CIK 1818794 CUSIP 26818M108 13F (30d) 16 filings 16 filers Visit website Investor relations